ALISKIREN, OBAT ANTIHIPERTENSI BARU DENGAN MEKANISME PENGHAMBAT RENIN
Hypertension is a chronic disease with a prevalence reaching 1 billion people around the world. Hypertension is the major treatable risk factor for cardiovascular disease, which remains the leading cause of death in the industrialized world. Despite the risks associated with the condition, the major...
Main Author: | Diana Holidah |
---|---|
Format: | Article |
Language: | English |
Published: |
Mulawarman University
2011-12-01
|
Series: | Journal of Tropical Pharmacy and Chemistry |
Online Access: | https://jtpc.farmasi.unmul.ac.id/index.php/jtpc/article/view/34 |
Similar Items
-
Persistensi Penggunaan Obat Antihipertensi pada Pasien Hipertensi Rawat Jalan
by: Nurmainah Nurmainah, et al.
Published: (2013-08-01) -
Profil Penggunaan Obat Antihipertensi di RSUD Mas Amsyar Kasongan Kabupaten Katingan
by: Syahrida Dian Ardhany, et al.
Published: (2018-05-01) -
PENYAKIT MALARIA DAN MEKANISME KERJA OBAT-OBAT ANTIMALARIA
by: Roihatul Muti’ah
Published: (2013-05-01) -
Benarkah Obat Penghambat Pompa Proton Meningkatkan Risiko Infark Miokard?
by: Yoga Yuniadi
Published: (2016-02-01) -
Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy
by: Kalathil K Sureshkumar
Published: (2008-12-01)